Phreesia Inc’s filing revealed that its Principal Accounting Officer Gunzburg Janet unloaded Company’s shares for reported $20836.0 on Apr 18 ’24. In the deal valued at $22.85 per share,912 shares were sold. As a result of this transaction, Gunzburg Janet now holds 35,220 shares worth roughly $0.73 million.
Then, Linetsky David sold 269 shares, generating $6,146 in total proceeds. Upon selling the shares at $22.85, the SVP, Life Sciences now owns 7,087 shares.
Before that, Indig Chaim sold 3,392 shares. Phreesia Inc shares valued at $77,532 were divested by the Chief Executive Officer at a price of $22.86 per share. As a result of the transaction, Indig Chaim now holds 1,222,005 shares, worth roughly $25.19 million.
Truist initiated its Phreesia Inc [PHR] rating to a Buy in a research note published on February 26, 2024; the price target was $35. A number of analysts have revised their coverage, including DA Davidson’s analysts, who increased its forecast for the stock in mid January from “a Neutral” to “a Buy”. Barclays began covering PHR with “an Overweight” recommendation on January 03, 2024. Stephens started covering the stock on April 12, 2023. It rated PHR as “an Overweight”.
Price Performance Review of PHR
On Friday, Phreesia Inc [NYSE:PHR] saw its stock jump 0.73% to $20.61. Over the last five days, the stock has lost -5.02%. Phreesia Inc shares have fallen nearly -10.97% since the year began. Nevertheless, the stocks have fallen -34.53% over the past one year. While a 52-week high of $34.98 was reached on 02/12/24, a 52-week low of $12.05 was recorded on 04/25/24. SMA at 50 days reached $23.76, while 200 days put it at $22.68. A total of 0.5 million shares were traded, compared to the trading of 0.52 million shares in the previous session.
Levels Of Support And Resistance For PHR Stock
The 24-hour chart illustrates a support level at 20.31, which if violated will result in even more drops to 20.00. On the upside, there is a resistance level at 20.97. A further resistance level may holdings at 21.32. The Relative Strength Index (RSI) on the 14-day chart is 37.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.58%. Stochastics %K at 12.36% indicates the stock is a buying.
The most recent change occurred on January 04, 2023 when Needham resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $40.
